Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
sorafenib (nexavar) (1 trial)
Carcinoma (Phase 3)
Carcinoma, Hepatocellular (Phase 3)
Trials (1 total)
Trial APIs (1 total)